Limited chemotherapy and shrinking field radiotherapy for osteolymphoma (primary bone lymphoma): Results from the Trans-Tasman radiation oncology group 99.04 and Australasian Leukaemia and lymphoma group LY02 prospective trial
- David Christie*
- , Keith Dear
- , Thai Le
- , Michael Barton
- , Andrew Wirth
- , David Porter
- , Daniel Roos
- , Gary Pratt
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
28
Citations
(Scopus)